Nymox Officially Granted Extension to Regain Listing Requirements

Provided By Globe Newswire

Last update: Mar 15, 2023

IRVINE, Calif., March 15, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the “Company”) has officially been granted by NASDAQ an additional period until July 3, 2023 to regain compliance with NASDAQ listing requirements, the Company reported today.